Sponsor Check › Issuer
Corporation · organized in DELAWARE · formed more than five years before filing · NEW YORK, NY · SEC CIK 1551306 · formerly Auxogyn Bioscience, Inc.; Auxogyn, Inc.; Auxogyn Inc
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Jun 29, 2016 · Courts (RECAP) last checked: Oct 23, 2026, 11:54 PM ET · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:54 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:54 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
No public statement by this issuer has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known only from an approved profile claim or the Form ADV of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this issuer yet.
0 of 5 offerings report sales commissions; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Jun 29, 2016 D File 021-266012 | $0 | $0 | $0 Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. | None listed on this filing |
| EDGAR ↗ | Mar 19, 2015 D File 021-236224 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 16, 2013 D File 021-202949 | $0 | $0 | $0 (est.) Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. | None listed on this filing |
| EDGAR ↗ | Jul 30, 2013 D File 021-200444 | $0 | $0 | $0 (est.) Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. | None listed on this filing |
| EDGAR ↗ | Jun 4, 2012 D File 021-179221 | $0 | $0 | $0 Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
0 recorded documents and 0 ownership records matched to Progyny, Inc. in the sources searched.
Not found in sources searched as of Oct 23, 2026, 8:59 PM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Florida DOR NAL roll (Hillsborough 39) roll year 2026 — loaded Oct 23, 2026, 8:54 PM ET; Florida DOR NAL roll (Dade 23) roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET. Not yet searched for this issuer (queued): NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.
Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Hillsborough County FL (recorded documents from Oct 14, 2026 forward; ownership from FL DOR roll 2026); Cook County IL (assessor ownership and deed/sale records, looked up per issuer when its page is viewed); Harris County TX and Dallas County TX (assessor ownership rolls only, 2026 roll; no deed, mortgage or sale records); Miami-Dade County FL (ownership from FL DOR roll only; Clerk recorded documents not yet searched). Recorder indexes for TX, AZ, IL and WA counties, mortgages and liens outside NYC and FL, lis pendens and foreclosure notices everywhere, Miami-Dade County FL recorded documents, Maricopa County AZ, King County WA, Salt Lake County UT, and all other counties are not yet searched. Last refresh: Oct 23, 2026, 11:30 PM ET; last subject check: Oct 24, 2026, 12:05 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|---|---|---|---|---|---|
| 021-266012 | Jun 29, 2016 EDGAR ↗ | Jun 29, 2016 D EDGAR ↗ | 0 | $20,000,000 | $14,773,147 | Other Health Care |
| 021-236224 | Mar 19, 2015 EDGAR ↗ | Mar 19, 2015 D EDGAR ↗ | 0 | $40,999,999 | $34,324,111 | Other Health Care |
| 021-202949 | Sep 16, 2013 EDGAR ↗ | Sep 16, 2013 D EDGAR ↗ | 0 | $9,885,049 | $5,525,340 | Other Health Care |
| 021-200444 | Jul 30, 2013 EDGAR ↗ | Jul 30, 2013 D EDGAR ↗ | 0 | $2,893,324 | $500,100 | Other Health Care |
| 021-179221 | Jun 4, 2012 EDGAR ↗ | Jun 4, 2012 D EDGAR ↗ | 0 | $18,000,001 | $18,000,001 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
| Filing | Form D filed Jun 29, 2016 SEC file no. 021-266012 · accession 0001551306-16-000006 |
|---|---|
| Raise progress | $14,773,147 sold of $20,000,000 offered (74%) · $5,226,853 remaining · first sale Jun 15, 2016 Issuer's note: Series B Preferred Stock; Common Stock issuable upon conversion |
| Filing timing | Date of first sale: Jun 15, 2016 · Form D filed: Jun 29, 2016 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 3,783 days (10.4 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 9 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 Issuer's note: Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. |
| Signed by | Edwin Neumann, CFO (Jun 29, 2016) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $20,000,000. Typical range: $829,831–$9,999,998. Investors: 9. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Mar 19, 2015 SEC file no. 021-236224 · accession 0001551306-15-000003 |
|---|---|
| Raise progress | $34,324,111 sold of $40,999,999 offered (84%) · $6,675,888 remaining · first sale Mar 4, 2015 |
| Filing timing | Date of first sale: Mar 4, 2015 · Form D filed: Mar 19, 2015 (15 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 4,252 days (11.6 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 29 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity · business combination transaction |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Gina Bartasi, Chief Executive Officer (Mar 18, 2015) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $40,999,999. Typical range: $829,831–$9,999,998. Investors: 29. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Sep 16, 2013 SEC file no. 021-202949 · accession 0001551306-13-000002 |
|---|---|
| Raise progress | $5,525,340 sold of $9,885,049 offered (56%) · $4,359,709 remaining · first sale Sep 6, 2013 Issuer's note: The total offering amount and total amount sold above both include amounts which will be received if the warrants are fully exercised. |
| Filing timing | Date of first sale: Sep 6, 2013 · Form D filed: Sep 16, 2013 (10 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 4,796 days (13.1 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 4 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Debt; Option, warrant or other right to acquire; Security to be acquired upon exercise; Other: (i) Ser B Pref Stock; Common Stock upon conversion,(ii) Pref Stock Warrant; Pref Stock upon exercise; Common Stock upon conversion, and (iii) convertible promissory notes; Pref Stock upon conversion; Common Stock upon conversion |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) Issuer's note: Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. |
| Signed by | Lissa Goldenstein, President and CEO (Sep 13, 2013) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $9,885,049. Typical range: $829,831–$9,999,998. Investors: 4. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Jul 30, 2013 SEC file no. 021-200444 · accession 0001551306-13-000001 |
|---|---|
| Raise progress | $500,100 sold of $2,893,324 offered (17%) · $2,393,224 remaining · first sale Jul 24, 2013 Issuer's note: The total offering amount above includes $2,393,224 which will be received if the warrant is fully exercised. |
| Filing timing | Date of first sale: Jul 24, 2013 · Form D filed: Jul 30, 2013 (6 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 4,840 days (13.3 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $500,100 |
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise; Other: (i) Series B Preferred Stock; Common Stock issuable upon conversion and (ii) Warrant to purchase Series B Preferred Stock; Series B Preferred Stock issuable upon exercise; Common Stock issuable upon conversion |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) Issuer's note: Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. |
| Signed by | Lissa Goldenstein, President and CEO (Jul 29, 2013) |
| Market context | Minimum investment: $500,100. Typical range for similar offerings: $10,000–$54,310. Offering size: $2,893,324. Typical range: $829,831–$9,999,998. Investors: 1. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Jun 4, 2012 SEC file no. 021-179221 · accession 0001551306-12-000001 |
|---|---|
| Raise progress | $18,000,001 sold of $18,000,001 offered (100%) · $0 remaining · first sale May 30, 2012 |
| Filing timing | Date of first sale: May 30, 2012 · Form D filed: Jun 4, 2012 (5 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 5,260 days (14.4 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 4 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $1,000,000 |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 Issuer's note: Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. |
| Signed by | Lissa Goldenstein, President and CEO (Jun 1, 2012) |
| Market context | Minimum investment: $1,000,000. Typical range for similar offerings: $10,000–$54,310. Offering size: $18,000,001. Typical range: $829,831–$9,999,998. Investors: 4. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Jun 29, 2016. Industry as reported, by offering: All 5 offerings reported: Other Health Care (2012–2016).
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|---|---|---|---|
| Beth Seidenberg | Director | NY | Jun 4, 2012 → Jun 29, 2016 on 5 of 5 filings listed on the latest filing | 28 other issuers |
| Edwin Neumann | Executive Officer | NY | Jun 29, 2016 on 1 of 5 filings listed on the latest filing | 3 other issuers |
| Fred Cohen | Director | NY | Mar 19, 2015 → Jun 29, 2016 on 2 of 5 filings listed on the latest filing | 23 other issuers |
| Gina Bartasi | Executive Officer, Director | NY | Mar 19, 2015 → Jun 29, 2016 on 2 of 5 filings listed on the latest filing | 2 other issuers |
| Hakan Goker | Director | NY | Jun 29, 2016 on 1 of 5 filings listed on the latest filing | — |
| Kathy Harris | Director | NY | Mar 19, 2015 → Jun 29, 2016 on 2 of 5 filings listed on the latest filing | 2 other issuers |
| Linda Mintz | Director | NY | Mar 19, 2015 → Jun 29, 2016 on 2 of 5 filings listed on the latest filing | 2 other issuers |
| Simeon George | Director | NY | Jun 4, 2012 → Jun 29, 2016 on 5 of 5 filings listed on the latest filing | 32 other issuers |
| Darrin Uecker | Executive Officer, Director | CA | Mar 19, 2015 on 1 of 5 filings not listed on the latest filing (Jun 29, 2016) | 2 other issuers |
| Kathryn Tunstall | Director | CA | Jul 30, 2013 → Mar 19, 2015 on 3 of 5 filings not listed on the latest filing (Jun 29, 2016) | — |
| Mark Weeks | Executive Officer | CA | Mar 19, 2015 on 1 of 5 filings not listed on the latest filing (Jun 29, 2016) | 5 other issuers |
| Nilesh Kumar | Director | CA | Jun 4, 2012 → Mar 19, 2015 on 4 of 5 filings not listed on the latest filing (Jun 29, 2016) | — |
| Laura Francis | Executive Officer | CA | Jul 30, 2013 → Sep 16, 2013 on 2 of 5 filings not listed on the latest filing (Jun 29, 2016) | 2 other issuers |
| Lissa Goldenstein | Executive Officer, Director | CA | Jun 4, 2012 → Sep 16, 2013 on 3 of 5 filings not listed on the latest filing (Jun 29, 2016) | — |
| Mark Gudiksen | Director | CA | Jun 4, 2012 → Sep 16, 2013 on 3 of 5 filings not listed on the latest filing (Jun 29, 2016) | 2 other issuers |
| Bob Michitarian | Executive Officer | CA | Jul 30, 2013 on 1 of 5 filings not listed on the latest filing (Jun 29, 2016) | 1 other issuer |
| Greg Garfield | Executive Officer | CA | Jun 4, 2012 on 1 of 5 filings not listed on the latest filing (Jun 29, 2016) | 10 other issuers |
| Greg Johnstone | Executive Officer | CA | Jun 4, 2012 on 1 of 5 filings not listed on the latest filing (Jun 29, 2016) | — |
| Rene Reijo Pera | Director | CA | Jun 4, 2012 on 1 of 5 filings not listed on the latest filing (Jun 29, 2016) | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings with the same first and last name and no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Other issuers listing the same people (showing 40 of 114):
Shared address: this business address appears on no other issuer's filings in our index. As of Oct 23, 2026, 5:45 PM ET.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Not yet searched. Sources to be searched: SEC Investment Adviser Information Reports — Form ADV data for SEC-registered advisers and exempt reporting advisers (file dated 2026-10-02); SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet searched.
Sources to be searched: the sponsor's own website (known only from an approved profile claim or the matched adviser's Form ADV) for Meta Pixel ids and Facebook / Instagram page links; Meta Ad Library API: not yet searched (API access pending). We never read facebook.com or instagram.com; readers get a link to Meta's public Ad Library instead.
Not yet collected.
Sources to be searched: sponsor website, Internet Archive, press index (GDELT), Form ADV. A sponsor's website is known only from an approved profile claim or the Form ADV of its matched adviser (Item 1.I); we never look it up elsewhere and never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for NY yet).
Export this report as PDF (all source links + data timestamp; members · included free during the launch period) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.
The complete public-record profile for Progyny, Inc., plus the weekly new-filings list.
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Free. Get the "Claimed by sponsor" chip and a confirmed contact for corrections. Claiming never changes the public-record section.